Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
francesca.donnellan@paediatrics.ox.ac.uk

Francesca Donnellan

Recent publications

Structural basis for synergistic antibody protection against the essential malaria invasion complex protein RIPR

Williams BG. et al, (2025)

Cross reactive responses between filovirus species amongst a cohort of Ebolavirus Zaire survivors in Guinea, West Africa

Jiwa Y. et al, (2024), EUROPEAN JOURNAL OF IMMUNOLOGY, 54, 82 - 82

A review of broadly protective monoclonal antibodies to treat Ebola virus disease.

Rijal P. and Donnellan FR., (2023), Curr Opin Virol, 61

Identification and characterisation of candidate monoclonal antibody Ebolavirus therapeutics

Donnellan F., (2022)

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.

Ramasamy MN. et al, (2021), Lancet, 396, 1979 - 1993

More publications